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ETHICAL AND LEGAL DILEMMAS
IN INFERTILITY TREATMENT
ABSTRACT: One of the main characteristics of the new millennium is the affirma-
tion of human rights in all aspects of human existence, with the intention of turning decla-
rative statements into reality. Development of up-to-date assisted reproductive technologies
(ART) and their application in infertility treatment have raised numerous ethical, legal, reli-
gious, social and other questions. In vitro fertilization, donation of gametes, embryos and
pre-embryos, cryopreservation of gametes, embryos, ovarian and testicular tissues, embryo
transfer, genetic reproductive techniques, cloning and other sophisticated methods used in
infertility treatment require cooperation between the medical and legal professions. Ethical
aspects of human reproduction and assisted fertilization are based on full respect of the life
of an individual even before conception, from pre-embryo stage, via embryo stage and fetus
stage to a newborn infant. Regarding investigative and clinical projects, this standpoint im-
plies the legalization of all ART procedures, unencumbered exchange of information and
consensus about their application, and adherence to the basic ethical principles of auto-
nomy, benefit, justice and common welfare. Ethical postulates provide unequivocal directi-
ons in the creation of new life and resolve all possible ethical dilemmas, protecting the
rights of doctors and participant in relevant procedures alike and reasserting the crucial
principle — respect of human dignity.
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INTRODUCTION
Infertility is a topical problem in gynecology, which requires delicate ap-
proach, analysis and treatment. Causes of infertility, presently encountered in
about 15—20% of couples, are numerous: tubal, ovarian, anatomical, immuno-
85logical, endometriosis, cervical, psychological, idiopathic and male factors,
whereat the infertility is most often multifactorial in nature. Developments in
reproductive biology have enabled infertility treatment by means of assisted
reproductive techniques (ART) and/or introduction of up-to-date methods for
reproductive function restoration. The term „assisted reproduction" is associa-
ted with certain treatments which give hope to many — patients, clinical per-
sonnel, researchers — but which also open numerous ethical, legal, religious
and social questions (P a p p, 2000).
In vitro fertilization (IVF), donation of gametes, embryos and pre-em-
bryos, cryopreservation of gametes, embryos, ovarian and testicular tissues,
embryo transfer, genetic reproductive techniques, cloning and other sophistica-
ted methods used in infertility treatment require cooperation of medical, ethical
and legal professions, with the aim of combing research work and individuali-
zed clinical approach. Ethical aspects of human reproduction and assisted ferti-
lization are based on full respect of the life of an individual even before con-
ception, from pre-embryo stage, via embryo stage and fetus stage to a newborn
infant. Regarding investigative and clinical projects, this standpoint implies the
legalization of all ART procedures, unencumbered exchange of information
and consensus about their application, and adherence to the basic ethical prin-
ciples of autonomy, benefit, justice and common welfare.
In 1990 in the U. K., the Parliament passed the Human Fertilization and
Embryology Act (HUFE) which provides legislation for the control of the pro-
cedures of assisted reproduction. In our country, Ethical Committee of the
Yugoslav Section for Fertility and Sterility made a draft of the ethical code on
assisted reproduction, which is going to be legislated in the near future (1990,
M i l a å i ã, 2000). The HUFE Act requires the experts engaged in assisted re-
production to consider „the welfare of the child born as a result of the treat-
ment (including the child's need for a father), and any other child that may be
affected by its birth". The Human Fertilization Act permits the use of embryos
for research in five categories: for promoting the treatment of infertility; for
improving the knowledge of the causes of congenital diseases; for improving
the knowledge of the causes of miscarriages; for developing more effective
techniques of contraception, and for developing methods of detection of the
presence of gene or chromosome abnormalities in embryos before implanta-
tion. After 23 years from the birth of the first IVF child, the necessity for em-
bryo research, and its implications for the status of the embryo as an entity, is
less challenging than in the previous decades, in particular at a time when the
therapeutic potentials of embryo stem cells provides convincing arguments re-
garding its necessity and further analysis (S t r o n g, 1998).
Law and ethics are indeed in an inevitable interaction with each other, as
two systems of normative ordering, which sometimes overlap and are someti-
mes in conflict. On one hand, the law may seem a more powerful instrument
than ethics, because its provisions are more authoritatively and comprehensi-
vely presented by political legislation and courts, more systematic and more
transparent, while its use is more practical, instrumentally versatile and institu-
tionally challengeable. On the other hand, the law is seen to lack an ethical di-
mension, to be crudely pragmatic at best, and impoverished in its capacity to
86educate and inspire those it governs to distinguish the right conduct from
wrong. The law sets a framework for practical utilization of ethical choices,
but the ethics sets limitations that are voluntarily obeyed, as expressed through
respect for the law, which in its turn asserts the merits of the society it go-
verns (D i c k e n s, 1999).
Before undergoing the various procedures of the assisted reproductive
techniques, patients should be fully acquainted with the following: how the
treatment will be carried out, how long it will take, how effective it will be
and what possible complications are, whereat they have to sign their consent
for the performance of the treatment. Gamete and embryo donation procedures
are absolutely secret, except in rare and legally foreseen cases, while other tre-
atments (in vitro fertilization — IVF, intrauterine insemination of husband's
spermatozoa — IUI, intracytoplasmic sperm injection — ICSI) can also be
made secret at the explicit request of patients. The Yugoslav Ethical Commit-
tee is of the opinion that it is indispensable to establish a center for registra-
tion of all donation data (M i l a å i ã, 2000). Legally controlled secrecy and
conscious consent of the patient are significant characteristics in the field of
reproductive medicine, ensuing from the establishment of the constitutional
right to privacy in reproductive treatment, and the reactions of political and
moral opponents to the realization of such rights (R o c k e t t et al., 2000).
DONATION OF GENETIC MATERIAL
Genetic material donation has become an integral part of infertility treat-
ment. Donations of spermatozoa, oocytes, embryos and pre-embryos (embryo
not older than 14 days) are successful in the medical and technical sense and
ethically approved. Medical problems and ethical dilemmas that require under-
standing and evaluation are: selection of donors, evaluation of recipients,
quality control of genetic material, relationship between biological and social
parents, and protection of the rights of offsprings through specially legislated
decisions. Sperm donation has to be anonymous, and the donors cannot be
known donors, friends or relatives.
Oocyte donation is also ethically permissible in specific cases: in patients
with premature ovarian failure and regular menopause, in patients with inferi-
or-quality oocytes and in patients after several unsuccessful IVF treatments. In
order to avoid a long waiting period, different procedures to recruit oocyte do-
nors are proposed, such as oocyte-sharing (donors share their oocytes with an
anonymous recipient and in return, recipients share the costs of treatment of
the donor) and the recruitment of a donor by the patients themselves. Attention
should be paid to possible psychological consequences of this decision (K a h n
et al., 1998, B a e t e n s, 2002).
Indications for embryo donation are women without oocytes and men
with azoospermia, in which cases only embryos obtained from spermatozoa
and oocytes of mutually unknown donors can be donated. Embryo donation
can be achieved in two ways: (I) using a combination of oocytes and sperm
donation — such donors should already have been properly counseled; and (II)
87using spare cryopreserved embryos from patients who have already been suc-
cessful and have consented to the donation of their remaining embryos. The
standpoint of the Yugoslav Ethical Committee is that embryos have certain
moral status, hence they cannot be preserved longer than 14 days (until „pri-
mitive streak" appearance), with permission to use the treatments that do not
diminish the genetic status of the embryo (embryo defragmentation and oo-
plasm transfer, M i l a å i ã, 2000). Although in the U.S.A. donation of cou-
ples' embryos has been permitted, very few couples decide to donate their em-
bryos (a greater percentage preserves the embryos for possible future use),
however, as proved in studies, which is interesting and important, transfer of
„donated" couples' embryos has resulted in a high percentage of successful
pregnancies per treated cycle (50%, V a n V o o r h i s et al., 1999). Pre-em-
bryo banks are to be specifically legalized and issued appropriate individual
permits; the concerned professional medical and social institutions would have
to take into consideration the interests of infertile couples, but also the inte-
rests of the embryo, i.e., of future descendants (E i s e n b e r g, 1998).
CRYOPRESERVATION OF GENETIC MATERIAL
Sperm and embryo cryopreservation is permitted and they can be preser-
ved up to 10 years. Sperm cryopreservation has long been routine and helpful
in preserving the fertility potential of many young men treated for iatrogenic
sterility or threatened by cancer. Oocyte cryopreservation, however, is not per-
mitted in any of the countries belonging to the International Federation of Fer-
tility Societies (IFFS).
Ovarian tissue cryopreservation is permitted, with significant prospects
for clinical use in reproductive medicine and oncology. Ovarian cryopreserva-
tion, which lately has been in the focus of experimental research, opens new
moral and ethical dilemma, requiring critical consideration for tissue preserva-
tion („bank"), and also require working out specific instructions by medical,
ethical and legal experts on the criteria for future clinical use and benefits of
such procedures (D e W e r t et al., 2000).
POSTHUMOUS REPRODUCTION
Recent events posing ethical dilemmas relate to posthumous reproduction,
pre-implantation genetic diagnosis (PGD) and cloning. They illustrate the diffi-
culties for closed, legally controlled systems to forecast all the possibilities of
scientific progress and ethical dilemmas arising from it. The advent of suc-
cessful techniques of spermatozoon and embryo cryopreservation makes the
birth of a child whose genetic father is dead technically possible, following the
usual period deemed legally necessary to recognize the paternity of the posthu-
mous child. Most of the centers for infertility treatment in the U. K. support
the idea of posthumous reproduction, hence the posthumous treatment is per-
mitted provided and explicit prior written consent has been given after the ga-
88mete(s) provider(s) had received counsel. General attitude is that each case
should be individually analyzed and approved by a multidisciplinary commit-
tee consisting of a gynecologist, a psychiatrist, a sociologist, a clergyman and
other appropriate specialists (B e n s h u s h a n et al., 1998).
PREIMPLANTATION GENETIC DIAGNOSIS
Preimplantation genetic diagnosis (PGD) is a result of development and
convergence of assisted reproduction techniques and genetic methods, allowing
the couples at risk an early diagnosis of hereditary diseases, even before the
conception. PGD, however, triggers the fear of potential genetic manipulation
and of getting closer to criminal eugenics, and therefore the standpoint of the
Yugoslav Ethical Committee is that PGD is justified only in medically indica-
ted cases. Within the framework of infertility treatment, pre-implantation gene-
tic diagnosis is part of a range of potential diagnosis options, which help our
patients when making an important decision about screening their future child
from serious diseases (P a p p, 2000; M i l a å i ã, 2000).
CLONING
Human reproductive cloning is unjustified and unnatural for it offends
human dignity and violates the individual rights to genetic uniqueness. One
can consider reproductive cloning of embryos by means of nucleus transplan-
tation or embryo splitting, and the ethical aspects in the context of genetic re-
productive techniques are to be evaluated separately. Many countries and insti-
tutions have analyzed possibilities of therapeutic cloning when other alternati-
ves are exhausted, as well as the cloning within the framework of genetic en-
gineering with the aim of producing appropriate human proteins.
Therapeutic cloning technology serves to culture stem cells that are gene-
tically identical to those of the patient, with an aim of replacing diseased cells,
for example in nerves damaged by neurodegenerative disorders, in the heart
muscle affected by infarction, in diabetes or in liver damaged by poisoning.
Stem cells may be derived from the embryo (more precisely, from blastocysts),
the fetus or the adult. There are several types of embryonic stem (ES) cells:
those issued from blastocysts either as supernumerary or created de novo and
those created by nuclear transfer from somatic cells (SCNT). The latter met-
hod is usually referred to as cloning (S h e n f i e l d, 2002).
The final report of the European Group on Ethics (EGE), made public in
November 2000, forbids reproductive cloning. It deems ethically unacceptable
to create embryos from donated gametes, because supernumerary embryos are
an alternative available source. In the case of embryos obtained by SCNT,
extreme concern is voiced, despite the awareness that the creation of such em-
bryos may be the most effective way for obtaining pluripotent stem cells gene-
tically identical to the patient's and thus obtaining perfectly compatible tissues
with the aim of avoiding rejection after transplantation (2000). Nevertheless,
the concerned scientists agree that research should continue with all sources of
89stem cells, as we cannot yet know which source — if any — is going to fulfill
the therapeutic expectations.
Cloning is due to receive extensive legislation, but is has to be carefully
and selectively performed in order to make room for further improvements in
this field of research for the benefit of the entire mankind (D e W e r t, 2000,
L u p t o n, 1999).
CONCLUSION
Sex selection, multiple pregnancies and embryocide, surrogate parentage
and treatment of older women open numerous ethical and legal dilemmas and
call for multidisciplinary and expert approach to analyzing each individual ca-
se, as well as to defining clear ethical and legal regulations, open to correction
in respect to further investigative work. Ethical postulates provide unequivocal
directions in the creation of new life and resolve all possible ethical dilemmas,
protecting the rights of doctors and participant in relevant procedures alike and
reasserting the crucial principle — respect of human dignity. Defined legal
principles are to be reconciled with the „natural laws" for the sake of protec-
tion of the freedom of thought and the right of individual choice and for the
realization of the goal aimed at the preservation of life and justification of the
purpose of existence.
REFERENCES
P a p p, Z., U r b a n c s e k, J. (2000): Professional and ethical challenges in reproduc-
tive biology and genetics at the beginning of the millennium, Orv Hetil, 141(24):
1327—42.
Human Fertilization and Embryology Act (1990): United Kingdom.
M i l a å i ã, D. (2000): Draft of ethical codex on assisted reproduction Proceedings of
XIV Yugoslav Symposium on Fertility and Sterility, Belgrade, 122—5.
S t r o n g, C. (1998): Teaching medical ethics and law within medical education: a mo-
del for the UK, J. Med. Ethics, 24(3): 188—92.
D i c k e n s, B. M. (1999): Reproductive health and legal duties of medical confidentia-
lity, Med. Law; 18(2—3): 217—23.
R o c k e t t, L. R. (2000): Legal issues affecting confidentiality and informed consent in
reproductive health, J. Am. Med. Women's Assoc., 55(5): 257—60.
K a h n, J. P. (1998): The ethics of egg donation, Minn. Med., 81(10): 12—5.
B a e t e n s, P. (2002): Oocyte donation. In: Boivin, J., Kentenich, H. (eds.) Guidelines
for Counseling in Infertility. ESHRE Monographs: 33—4.
V a n V o o r h i s, B. J., G r i n s t e a d, D. M., S p a r k s, A. E., et al. (1999): Esta-
blishment of a successful donor embryo program: Medical, ethical, and policy is-
sues, Fertil. Steri., 71(4):604—8.
E i s e n b e r g, V. H., S c h e n k e r, J. G. (1998): Pre-embryo donation: Ethical and
legal aspects, Int. J. Gynaaecol. Obstet., 60(1):51—7.
D e W e r t, G., D e B e a u f o r t, I. D. (2000): Cryopreservation of ovarian tissue
open for discussion, Ned Tijdschr Geneeskd, 1444(15): 692—4.
90B e n s h u s h a n, A., S c h e n k e r, J. G. (1998): The right to an heir in the era of as-
sisted reproduction, Hum. Reprod.: 13(5): 1407—10.
S h e n f i e l d, F. (2002): Cloning: reproductive, therapeutic or not at all? In: Shen-
field, F., Sureau, C. (eds.) Ethical Dilemmas in Reproduction, New York, USA:
Parthenon Publishing: 87—97.
The European Group on Ethics and New Technologies to the European Commission
(2000): Adoption of an opinion on ethical aspects of human cell research and use,
Paris, 14 Nov. 2000, revised Jan. 2001, Secretariat of the Group, Brussels.
D e W e r t, G. M., G e r a e d t s, J. P. (2000): Cloning: applications in humans. II Ethi-
cal considerations, Ned Tijdschr Geneeskd: 144(20): 926—31.
L u p t o n, M. L. (1999): To clone or not to clone — whether the law? Med. Law:
18(1): 107—23.
ETIÅKO PRAVNE DILEME U TRETMANU INFERTILITETA
Svetlana Dragojeviã-Dikiã,1 Saveta Draganiã,2
Srðan Dikiã3 i Vladimir Pilija4
1 Ginekološko-akušerska klinika „Narodni front",
Narodnog Fronta 62, 11000 Beograd, Srbija i Crna Gora
2 Institut za mentalno zdravqe, Medicinski fakultet,
11000 Beograd, Srbija i Crna Gora
3 Univerzitetska klinika „Beÿanijska kosa",
Medicinski fakultet, 11000 Beograd
4 Kliniåki centar Novi Sad, Institut za sudsku medicinu,
Hajduk Veqkova 7, 21000 Novi Sad
Rezime
Jedno od osnovih obeleÿja novog milenijuma je afirmacija qudskih prava
u svim oblastima qudskog bitisawa sa teÿwom oÿivotvorewa deklarativnih u
realistiåko postulirane odnose. Razvoj savremenih asistiranih reproduktiv-
nih tehnika (ART) u tretmanu infertiliteta otvorio je mnogobrojna etiåka,
pravna, religiozna i socijalna pitawa: in vitro fertilizacija; donacija gameta,
embriona i preembriona; krioprezervacija gameta, embriona, ovarijalnog i te-
stikularnog tkiva; embrio transfer, genetske reproduktivne tehnike; klonira-
we i druge sofisticirane metode u rešavawu vaÿnog i delikatnog ÿivotnog i
medicinskog pitawa — infertiliteta, zahtevaju kooperaciju medicinske pro-
fesije i etiåko-pravne struke, u ciqu povezivawa nauåno-istraÿivaåkog rada i
odgovarajuãeg, mudrog i individualizovanog kliniåkog pristupa. Etiåki aspek-
ti humane reprodukcije, kao i asistirane fertilizacije, zasnivaju se na po-
štovawu ÿivota jedinke i pre uspostavqawa koncepcije, od preembrionalnog
stadijuma, preko embrionalnog stadijuma, stadijuma fetusa i novoroðenog dete-
ta. Ovakav stav u daqim istraÿivaåkim i kliniåkim poduhvatima podrazumeva
legalizaciju svih procedura u okviru asistiranih reproduktivnih tehnika, in-
formisanost i saglasnost o wihovom sprovoðewu, uz poštovawe osnovnih etiå-
kih principa: autonomije, koristi, pravde i opšte dobrobiti. Etiåki postula-
ti u postupcima kreirawa novog ÿivota pomaÿu svojim jasnim uputstvima u re-
šavawu moguãih etiåkih dilema, štiteãi prava lekara i svih uåesnika u odgo-
varajuãim procedurama, uz uvaÿavawe krucijalnog principa — poštovawa qud-
skog dostojanstva.
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